Joel Solomon

Across North America, social and environmental entrepreneurs are designing innovative solutions to some of the world’s most pressing problems. Renewal2 one of a handful of funds in North America that provides investors the unique opportunity to participate in the development of business at the forefront of social and environmental change while achieving market-rate returns.

My first significant job began during University when I got involved with Jimmy Carter's first campaign for President. The deeper reason for my support had to do with the values, thoughtfulness and compassion of President Carter.

The current state of the capital markets and the U.S. financial system has left many investors looking for an alternative in their investment portfolios. Social venture funds like Renewal2 offer an opportunity to investors to achieve excellent returns while helping to grow companies at the forefront of social and environmental innovation.

Paul Richardson, President of Renewal2 Investment Fund, is pleased to announce the first close of the Fund at over $16 million. Renewal2 is one of a handful of funds in North America that focus on companies which have positive environmental, social and financial returns.

Join Paul Richardson, President and Joel Solomon, Chairman on a call to learn more about. The Renewal team is building on their successful 15-year track record of high-impact investing with the launch of this fund.

Join Paul Richardson, President and Joel Solomon,
Chairman on a call to learn more about Renewal2, a fund which is
designed to achieve excellent returns by providing early and growth
capital, as well as guidance, to social entrepreneurs.

I had a new birthday on November 14. That was the anniversary of my first full year with a new kidney. There's no way I can describe the gratitude and joy that I feel. People ask how long it took to recover. That recovery continues, because it has taken me far beyond the health of even two years before the transplant. In fact, best I can judge, I'm ten years younger than when the surgeon marked the spot with his felt pen.